Ross Edmund Burke Jr. 13D/13G Filings for AzurRx BioPharma, Inc. (AZRX)

Ross Edmund Burke Jr. 13D and 13G filings for AzurRx BioPharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-02-10
09:54 am
Purchase		2021-01-1213DAzurRx BioPharma, Inc.
AZRX		Ross Edmund Burke Jr.309,657
5.890%		24,914increase
(+8.75%)		Filing
2020-08-11
4:05 pm
Purchase		2020-07-1613DAzurRx BioPharma, Inc.
AZRX		Ross Edmund Burke Jr.284,743
9.990%		17,006increase
(+6.35%)		Filing